4
Changes in Ownership
Adicet Bio, Inc. Filed Acc 0001209191-23-046102
Options or other derivatives
- SVP & Chief Medical Officer acquired 533,710 shares (grant or award)
- SVP & Chief Medical Officer returned 533,710 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Galimi Francesco · SVP & Chief Medical Officer
Table II: Derivative
12 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-14 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −113,652 | 0 | D |
| 2023-08-14 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +113,652 | 113,652 | D |
| 2023-08-14 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −77,269 | 0 | D |
| 2023-08-14 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +77,269 | 77,269 | D |
| 2023-08-14 | Returned to the company : show line 5 in the form Stock Option (Right to Buy) | −73,964 | 0 | D |
| 2023-08-14 | Grant or award : show line 6 in the form Stock Option (Right to Buy) | +73,964 | 73,964 | D |
| 2023-08-14 | Returned to the company : show line 7 in the form Stock Option (Right to Buy) | −26,625 | 0 | D |
| 2023-08-14 | Grant or award : show line 8 in the form Stock Option (Right to Buy) | +26,625 | 26,625 | D |
Loading xslF345X05/doc4.xml…